Review: could Revlimid cause Embolic stroke?
Summary: Embolic stroke is found among people who take Revlimid, especially for people who are female, 60+ old, have been taking the drug for < 1 month, also take medication Insulin, and have Myelodysplastic syndrome.
We study 42,903 people who have side effects while taking Revlimid from FDA and social media. Among them, 9 have Embolic stroke. Find out below who they are, when they have Embolic stroke and more.
You are not alone: join a mobile support group for people who take Revlimid and have Embolic stroke >>>
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. (latest outcomes from 42,996 Revlimid users)
Embolic stroke (stroke due to obstruction due to an embolus) has been reported by people with high blood pressure, birth control, stroke, high blood cholesterol, pain. (latest reports from 1,268 Embolic stroke patients)
On Jan, 1, 2015: 42,903 people reported to have side effects when taking Revlimid. Among them, 9 people (0.02%) have Embolic Stroke.
Time on Revlimid when people have Embolic stroke * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Embolic stroke||40.00%||40.00%||0.00%||0.00%||20.00%||0.00%||0.00% |
Gender of people who have Embolic stroke when taking Revlimid * :
|Embolic stroke||61.54%||38.46% |
Age of people who have Embolic stroke when taking Revlimid * :
|Embolic stroke||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||30.77%||69.23% |
Severity of Embolic stroke when taking Revlimid ** :
How people recovered from Embolic stroke ** :
Top conditions involved for these people * :
- Myelodysplastic syndrome (7 people, 77.78%)
- Multiple myeloma (6 people, 66.67%)
- Pain (4 people, 44.44%)
- Blood pressure increased (1 people, 11.11%)
Top co-used drugs for these people * :
- Insulin (4 people, 44.44%)
- Oxycontin (4 people, 44.44%)
- Dilaudid (4 people, 44.44%)
- Tarceva (4 people, 44.44%)
- Oxycodone hcl (4 people, 44.44%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Embolic Stroke while taking Revlimid?
You are not alone! Join a mobile support group:
- support group for people who take Revlimid and have Embolic Stroke
- support group for people who take Revlimid
- support group for people who have Embolic Stroke
Drugs in real world that are associated with:
Could your condition cause:
Can you answer these questions (Ask a question):
- Can i take acyclovir and cipro together
can I take cipro for a uti while taking acycovir for shingles
- After going off of revlimid can you expect an improvement in neuropathy
Switched from Velcade after 6 months on to Revlimid as a maintenance drug after a stem cell transplant. Have been on Revlimid for about 6 months and the neuropathy has progressed from my feet to halfway up my legs.
- I'm a 59 year old male. diagnosed 4 years ago. post transplant now 3 years. protein levels progressing. new drug regimen behind considered. has anyone supplemented diet with homeopathic vitamins, etc? (2 answers)
considering taking natural supplements
Vitamin D 2000 MG
- Should i take 15 mg mirtazapine while having multiple myeloma
my condition is being controlled so far
- Is there anyone who has information or experience with refractory multiple myeloma and the development of a second primary cancer in the colon (colon cancer)
Diagnosed May 2009 with Stage IV, IGg Kappa Multiple Myeloma. Presented with pneumonia, 2 rib fractures, anemia, elevated serum m-protein, over 100 bone lesions, 78% plasma cells in bone marrow. No organ involvement. Chromosomal mutations, deletions, and transposition. Evaluated as low risk. 52 X-Y. After Revlamid-Dexamethazone induction therapy, Underwent Autogus Stem Cell Transplant involving Cytoxian based mobilization, High Dose Melphlain Chemotherapy. Had good response and well tolerated. Residual disease evident by residual ledic lesions and plasma cell involvement at 5%. Then consolidation therapy in the form of VDT-Pace, off protocall, that resulted in complete profound remission. After which began maintenance therapy of revlimid, valcade, dex. Time to disease progression of 30 months. Refractory to RVD maintenance. Began 3 cycles VDT-Pace plus Melphalan. Thus contributing to current good partial remission of 3 months. Now under new maintenance of pomalyst, dex,
NOW, PET scan and follow-up colonscopy has confirmed a Second Primary Cancer discovered in the sigmoid colon as COLON CANCER. (super rare manifestation)
Currently, under the care of one of the top in the field of Multiple Myeloma. And had, until now considered myself rather educated on this condition..... Now, I am searching for others, i.e. patients, caregivers or professionals willing to shed light on this otherwise unknown journey of which I am about to embark. Any onsite or direction would be greatly appreciates.... I guess I am #140 of 55,600 studied MM patients!!
Thanks for your information and encouragement!!
More questions for: Revlimid, Embolic stroke
More reviews for: Revlimid, Embolic stroke
Comments from related studies:
From this study (2 days ago):
From this study (2 months ago):
Tumor on the pituitary gland
From this study (3 months ago):
After 11 cycles of revlimid 20 mg X 21 days swallowing tablets/capsules and firm lumpy food became difficult and sometimes obstructive around level of C6 vertebra (behind laryngeal cricoid).
Post a new comment OR Read more comments
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.